• No results found

The controversy over homocysteine and cardiovascular risk

N/A
N/A
Protected

Academic year: 2022

Share "The controversy over homocysteine and cardiovascular risk"

Copied!
9
0
0

Laster.... (Se fulltekst nå)

Fulltekst

Referanser

RELATERTE DOKUMENTER

The ev- idence of significantly increased prevalence of cardiovascular dis- ease and diabetes mellitus (DM) in both idiopathic normal pressure hydrocephalus (iNPH) (Eide &

We present data on the relation between betaine and plasma tHcy in 90 patients with cardiovascular disease before and during long-term intervention with folate, cobalamin, and

Because the Hordaland Homocysteine Study had previously shown an inverse association between moderate alcohol con- sumption and plasma tHcy concentrations in nonsmokers (16), we

Furthermore, our finding of markedly elevated plasma levels of reduced homocysteine in CVI patients, without simultaneous elevation of the other homocysteine species, correlated

population–based Prostate testing for cancer and Treatment (ProtecT) study to investigate whether plasma concentrations of folate, vitamin B 12 , and total homocysteine (tHcy)

High concentrations of plasma total homocysteine (tHcy) are associated with serious pregnancy complications, including pregnancy-induced hypertension, preeclampsia (1), and

Some prospective studies showed a strong association between tHcy and cardiovascular disease (9–13), some found weaker associations (14–17), and others, including the Mul- tiple

A n increased risk of ischemic heart disease has been observed in patients with elevated blood choline, 1 plasma total homocysteine (tHcy), 2 and betaine 3 levels, although